Gli anticoagulanti di ultima generazione Ida Martinelli Centro Emofilia e Trombosi A. Bianchi Bonomi Fondazione IRCCS Ca Granda - Ospedale Maggiore Policlinico.
Recent Developments In New Oral Anticoagulants Eric Watts Basildon Hospital.
Rivaroxaban compared with enoxaparin for the prevention of venous thromboembolism in acutely ill medical patients Alexander T Cohen On behalf of the MAGELLAN.
An Oncologists Perspective on Cancer and Thrombosis Gary H. Lyman, MD, MPH, FRCP(Edin) Professor of Medicine and Director Health Services, Effectiveness.
Paziente medico e chirurgico: schemi di trattamento Walter Ageno Dipartimento di Medicina Clinica Università dellInsubria - Varese.
Venous Thromboembolism Prophylaxis in Orthopedic Surgery Prepared for: Agency for Healthcare Research and Quality (AHRQ) .
A Systematic Analysis of VTE Prophylaxis in the Setting of Cancer Linking Science and Evidence to Clinical Practice— What Do Trials Teach? A Systematic.
Thrombosis in Cancer An Update on Risk Assessment, Prevention and Treatment Agnes Lee, MD, MSc, FRCPC University of British Columbia, Vancouver, BC June.
Medical Patients – VTE Prevention Dale W. Bratzler, DO, MPH Professor and Associate Dean, College of Public Health Professor of Medicine, College of Medicine.
Daniela Tormene MALATTIE TROMBOEMBOLICHE Anatomic theatre, Padua University.
Prevention Of Venous Thromboembolism In The Cancer Surgical Patient A K Kakkar Barts and the London School of Medicine and Thrombosis Research Institute,
Venous Thromboembolism Prophylaxis in Orthopedic Surgery
